# Bivalirudin

NDC: 52958-034
Generic name: Bivalirudin
Labeler / Manufacturer: Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20191023

FDA application: ANDA210031

## Active ingredients

- BIVALIRUDIN: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52958-034"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52958-034
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=61de12ff-e280-4bab-9804-43869ec45fa7